Han Lee, Ph.D, MBA

Han Lee is a biotechnology executive with corporate finance, strategy, and business development, and company building experience in the biopharmaceutical industry.  Prior to joining ImmPACT Bio, Dr. Lee most recently served as CFO of Neogene where he led the financial operations and investor relations activities for the company and played an instrumental role in the acquisition by AstraZeneca. Prior to that, Dr. Lee served as CFO of Arcellx, Inc., where he was an integral leader in the company’s clinical stage transition and successful financings. Earlier in his career, he worked in the Corporate Development and Ventures group at AstraZeneca, where he focused on M&A, corporate strategy, and management of the company’s portfolio of public and private investments. He has served as a pivotal member of two cell therapy biotechnology companies with successful exits and has also served as a corporate board member for multiple companies.

Dr. Lee earned a B.A. in genetics and minor in chemistry from the University of California, Berkeley, and a Ph.D. in genetics and an MBA from Yale University.